ArticleNucleic acids research2026
Reciprocal targeting of the unfolded protein response regulator Xbp1 and the DOM-A nucleosome remodeler in Drosophila.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The DOM-A complex regulates cell growth and proliferation in Drosophila. Like the orthologous human P400 complex, DOM-A combines two epigenetic effectors: a SWR1-type histone exchange enzyme, Dom-A, and the Tip60 acetyltransferase. We found Xbp1, a conserved transcription regulator of the unfolded protein response (UPR), as tightly associated with immunopurified DOM-A and explored the functional implications of this interaction. We biochemically determined the Xbp1 DNA recognition motif in chromatin-reconstituted Drosophila genomes. Intersection of the chromatin binding profiles for Xbp1 and Dom-A in proliferating cells and reciprocal protein depletion studies revealed two distinct modes through which Xbp1 binds chromatin. Xbp1 recruits Dom-A to motif-bearing promoters of genes involved in the UPR, such as Xbp1, Hsc70-3, and Gp93, and activates their transcription. Xbp1 also localizes to hundreds of high-confidence Dom-A binding sites that lack Xbp1 recognition motifs. These interactions depend on Dom-A, pointing to a 'reverse targeting' scenario. Upon depletion of Dom-A, Xbp1 protein levels, but not mRNA levels, are reduced. The Xbp1 may thus be stabilized upon binding to DOM-A. The complex interactions of Xbp1 and DOM-A in the genome bear potential to integrate signals from the UPR with the general, DOM-mediated regulation of cell growth and proliferation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.